探索心力衰竭中的外体的景观:一个文献计量分析
Hui Li1, Zhitao Li1, Qinghui Fu1
1Surgical Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
International journal of surgery (London, England)
|January 27, 2025
概括
外体对诊断和治疗心力衰竭 (HF) 有很大的前景. 研究趋势突出了它们在细胞通信,通过microRNAs进行诊断和使用介质干细胞衍生外体的疗法中的作用.
科学领域:
- 生物医学科学 生物医学科学
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
背景情况:
- 外体是参与细胞间通信的纳米级囊泡,携带各种生物分子.
- 它们因其作为心力衰竭 (HF) 的诊断标志物和治疗剂的潜力而得到认可.
研究的目的:
- 分析出版趋势,确定主要贡献者,并绘制出心力衰竭外体领域的研究热点.
- 提供当前研究环境的全面概述.
主要方法:
- 关于心力衰竭中的外体的出版物的图书统计分析.来自Web of Science核心收藏.
- 使用VOSviewer,CiteSpace,Excel和SRplot软件对数据进行可视化.
主要成果:
- 关于心力衰竭研究中的外体体的出版物迅速增加.
- 中国和美国是领先的国家,王利是最多产的作家.
- 关键的研究领域包括介质干细胞 (MSC),血管新生,微RNA,细胞间通信和MSC衍生的外体的治疗应用.
结论:
- 外体是心力衰竭研究中快速增长的兴趣领域.
- 了解研究环境可以加速基于外体的诊断和治疗HF的进展.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers
324
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324


